Press Releases > Mobile Medication Reference Apps May Not Adequately Warn of Medication Dangers - November 12, 2013

Mobile Medication Reference Apps May Not Adequately Warn of Medication Dangers - November 12, 2013

posted on 5:31 AM, June 26, 2014
Click here for a .pdf of this press release.
PRWeb ebooks - Another online visibility tool from PRWeb
A study published in the Journal of Medical Toxicology finds that mobile apps that help health
care practitioners with prescribing the correct dose of medications may not adequately warn of
the dangers of some of these drugs.
Phoenix, Arizona (PRWEB) November 12, 2013 -- A new study published in the Journal of Medical
Toxicology (JMT), the official journal of the American College of Medical Toxicology (ACMT), found that the
warnings offered by electronic medication reference programs used on smartphones vary significantly and
some may not adequately warn prescribersof dangers of medications. In the study, "Electronic Pharmacopeia: A
Missed Opportunity for Safe Opioid Prescribing Information?", seven such programs, which are widely used by
physicians when looking up the correct dose or other important information about a medication, were analyzed.
The researchers found that warnings about dangerous effects of certain medications were not prominently
displayed or not provided at all. The researchfocused on extended-release/long-acting opioids, a class of
medications that ranks among the most dangerous particularly when prescribed without great caution. “When
given to the wrong patient or at an incorrect dose the outcome of incorrect prescribing may be death,” says
study author Jeff Lapoint, DO, suggesting that understanding the safety issues around this class of drugs is
critical to prevent harm.
The seven programs were evaluated for their warnings regarding 6 medications. Only two programs contained a
warning placed in line with dosing information, requiring that it be viewed. Four offered a warning but placed
them in separate sections from the dosing information. One program made no mention of the boxed warning.
Boxed warnings, also known as ‘black box warnings’, are alerts that the US FDA may require on package
inserts for certain medications to indicate a significant risk of a serious or life-threatening adverse event.
The authors chose to study the opioid class of pain medications because it contains a boxed warning. “Given
the fact that FDA thought there were enough risks for a black box warning, it seems that this information
should be among the first items ones sees when looking up a drug in a reference, and certainly must be seen at
some point in the process,” says Lewis Nelson, MD another study author.
“There are no standards for how to display safety information in these apps, and there are concerns about overly
aggressive warnings, but it seems reasonable to expect some sort of warning,” said Dr. Lapoint. He goes on to
say that “while authorities disagree about the optimal use of warnings, there are few proven solutions to
preventing dangerous prescribing.”
ACMT is a professional, nonprofit association of physicians with recognized expertise in medical toxicology.
The College is dedicated to advancing the science and practice of medical toxicology through a variety of